Lansoprazole in Preterm Infants With Reflux

NCT01778101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Preterm Infants
Gastrointestinal Reflux

Interventions

DRUG: Lansoprazole

Sponsor

Seoul National University Hospital